The value of uterine myometrial vein assessment in predicting placental implantation and postpartum hemorrhage

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400084587

Enrollment

Unknown

Registered

2024-05-21

Start date

2024-06-01

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum hemorrhage

Interventions

Placental implantation group:NA

Postpartum hemorrhage group:NA

control group:NA

Eligibility

Sex/Gender

Female

Age

18 Years to 49 Years

Inclusion criteria

Inclusion criteria: (1) Singleton; (2) 18 years old = Age = 49 years old; (3) Our hospital conducts prenatal ultrasound examination; (4) Postpartum follow-up results;

Exclusion criteria

Exclusion criteria: (1) Twins and multiple pregnancies; (2) Poor patient compliance and poor likelihood of follow-up;

Design outcomes

Primary

Measure	Time frame
Uterine myometrial vein diameter;Dilated part of uterine myometrial vein;	—

Secondary

Measure	Time frame
Termination of gestational week;Postpartum bleeding volume;Newborn birth weight;Apgar score;	—

Countries

China

Contacts

Public ContactGuo Jianfeng

Yixing people's hospital

JianfengGuo752@163.com+86 133 0615 1568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026